JP2025508371A5 - - Google Patents

Info

Publication number
JP2025508371A5
JP2025508371A5 JP2024547419A JP2024547419A JP2025508371A5 JP 2025508371 A5 JP2025508371 A5 JP 2025508371A5 JP 2024547419 A JP2024547419 A JP 2024547419A JP 2024547419 A JP2024547419 A JP 2024547419A JP 2025508371 A5 JP2025508371 A5 JP 2025508371A5
Authority
JP
Japan
Prior art keywords
sequence
nucleic acid
sequence shown
domain
acid according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024547419A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025508371A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/062428 external-priority patent/WO2023154890A2/en
Publication of JP2025508371A publication Critical patent/JP2025508371A/ja
Publication of JP2025508371A5 publication Critical patent/JP2025508371A5/ja
Pending legal-status Critical Current

Links

JP2024547419A 2022-02-11 2023-02-10 Ｓｔｅａｐ１に結合するキメラ抗原受容体 Pending JP2025508371A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263309389P 2022-02-11 2022-02-11
US63/309,389 2022-02-11
PCT/US2023/062428 WO2023154890A2 (en) 2022-02-11 2023-02-10 Chimeric antigen receptors binding steap1

Publications (2)

Publication Number Publication Date
JP2025508371A JP2025508371A (ja) 2025-03-26
JP2025508371A5 true JP2025508371A5 (https=) 2026-02-10

Family

ID=87565154

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024547419A Pending JP2025508371A (ja) 2022-02-11 2023-02-10 Ｓｔｅａｐ１に結合するキメラ抗原受容体

Country Status (4)

Country Link
US (1) US20250144139A1 (https=)
EP (1) EP4476267A4 (https=)
JP (1) JP2025508371A (https=)
WO (1) WO2023154890A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024274301A1 (en) * 2023-05-16 2025-12-11 Fred Hutchinson Cancer Center Pro-inflammatory cytokine enhanced steap1 recombinant receptors
CN119113151B (zh) * 2024-08-01 2025-11-18 华中科技大学同济医学院附属同济医院 一种前列腺癌特异性细胞外囊泡荧光探针及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0717638A2 (pt) * 2006-10-27 2013-11-12 Genentech Inc Anticorpors e imunoconjugados e usos para os mesmos
TR201904484T4 (tr) * 2009-11-03 2019-05-21 Hope City Transdüse T hücre seçimine yönelik kesik epiderimal büyüme faktörü reseptörü (EGFRt).
PH12013501201A1 (en) * 2010-12-09 2013-07-29 Univ Pennsylvania Use of chimeric antigen receptor-modified t cells to treat cancer
EP2970985A1 (en) * 2013-03-14 2016-01-20 Fred Hutchinson Cancer Research Center Compositions and methods to modify cells for therapeutic objectives
WO2014165818A2 (en) * 2013-04-05 2014-10-09 T Cell Therapeutics, Inc. Compositions and methods for preventing and treating prostate cancer
CN105873952A (zh) * 2013-10-31 2016-08-17 弗莱德哈钦森癌症研究中心 经修饰的造血干细胞/祖细胞和非t效应细胞及其用途
ES2819553T3 (es) * 2014-12-03 2021-04-16 Juno Therapeutics Inc Métodos y composiciones para terapia celular adoptiva
AU2016306209B2 (en) * 2015-08-07 2023-07-06 Seattle Children's Hospital (dba Seattle Children's Research Institute) Bispecific CAR T-cells for solid tumor targeting
JP2018533930A (ja) * 2015-10-02 2018-11-22 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 二重特異性ｔ細胞活性化抗原結合分子
IL302560B2 (en) * 2015-10-13 2025-08-01 Hope City Chimeric antigen receptors containing a chlorotoxin domain
GB201518136D0 (en) * 2015-10-14 2015-11-25 Glaxosmithkline Ip Dev Ltd Novel chimeric antigen receptors
EP3448427A1 (en) * 2016-04-29 2019-03-06 CureVac AG Rna encoding an antibody
US11117936B2 (en) * 2017-11-10 2021-09-14 University of Pittsburg—Of the Commonwealth System of Higher Education Affinity-enhanced monomeric streptavidin chimeric antigen receptor (CAR)
WO2019200347A1 (en) * 2018-04-13 2019-10-17 Fred Hutchinson Cancer Research Center Methods for adoptive cell therapy targeting ror1
CN112166193A (zh) * 2018-05-21 2021-01-01 生物权威（英国）有限公司 具有经修饰的接头结构域的嵌合抗原受体及其用途
WO2019246593A2 (en) * 2018-06-22 2019-12-26 Fred Hutchinson Cancer Research Center Compositions and methods to target cll-1 and cd123 for the treatment of acute myeloid leukemia and related disorders
EA202190304A1 (ru) * 2018-07-18 2022-01-21 Эмджен Инк. Химерные рецепторы к steap1 и способы их применения
SG11202107976SA (en) * 2019-01-29 2021-08-30 Juno Therapeutics Inc Antibodies and chimeric antigen receptors specific for receptor tyrosine kinase like orphan receptor 1 (ror1)
CA3130671A1 (en) * 2019-02-07 2020-08-13 Board Of Regents, The University Of Texas Systems Glucuronoxylomannan (gxm) receptor chimeric antigen receptors and use thereof
AU2020315213A1 (en) * 2019-07-17 2022-02-03 National University Of Singapore Functional binders synthesized and secreted by immune cells
GB202208119D0 (en) * 2022-06-01 2022-07-13 Univ Oslo Hf Anti-steap1 car

Similar Documents

Publication Publication Date Title
JP7499813B2 (ja) 腫瘍壊死因子 （ｔｎｆ） スーパーファミリー受容体結合分子およびその使用
JP2023134735A5 (https=)
Hanssens et al. The antigen‐binding moiety in the driver's seat of CARs
JP2023059873A5 (https=)
JP2025508371A5 (https=)
US8669350B2 (en) TNF receptor Fc fusion proteins and in vivo methods of use
JP2020108398A5 (https=)
US20220249563A1 (en) Anti-dll3 chimeric antigen receptors and uses thereof
JP2020532969A5 (https=)
JP2024532485A5 (https=)
JP2018512145A5 (https=)
JP2023513157A5 (https=)
JP2019528683A (ja) 多量体ｇｉｔｒ結合分子及びその使用
JP2021512615A5 (https=)
JP2019528077A5 (https=)
JP2022542543A5 (https=)
JP2019525771A5 (https=)
JP2021526844A5 (https=)
CN102906112A (zh) Trail r2-特异性多聚体支架
CN109562165A (zh) 多聚ox40结合分子及其用途
JP2019528683A5 (https=)
JP2023512452A5 (https=)
JP2019533675A5 (https=)
Zhu et al. COMBODY: one‐domain antibody multimer with improved avidity
CA3173414A1 (en) Pd-1 agonist multimeric binding molecules